Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-Based Approach.

Nantakarn Pongtarakulpanit1, Anuradha Bishnoi2, Tanya Chandra3

  • 1N. Pongtarakulpanit, MD, Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA, and Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

PubMed
Summary

This study shows 3D imaging is a valid and responsive tool for assessing skin disease activity in dermatomyositis (DM). 3D image-derived rash measurements accurately predict disease severity scores.

Related Concept Videos